Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Non-surgical treatment of esophageal achalasia.

Literature DB >> 17007039

Non-surgical treatment of esophageal achalasia.

Abstract

Esophageal achalasia is an infrequent motility disorder characterized by a progressive stasis and dilation of the oesophagus; with subsequent risk of aspiration, weight loss, and malnutrition. Although the treatment of achalasia has been traditionally based on a surgical approach, especially with the introduction of laparoscopic techniques, there is still some space for a medical approach. The present article reviews the non-surgical therapeutic options for achalasia.

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 17007039 PMCID： PMC4100654 DOI： 10.3748/wjg.v12.i36.5763

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

28 in total

1. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study.

Authors: Luca Dughera; Edda Battaglia; Dario Maggio; Paola Cassolino; Pier Roberto Mioli; Antonio Morelli; Giorgio Emanuelli; Gabrio Bassotti
Journal: Drugs Aging Date: 2005 Impact factor: 3.923

2. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.

Authors: V Annese; G Bassotti; G Coccia; V D'onofrio; G Gatto; A Repici; A Andriulli
Journal: Aliment Pharmacol Ther Date: 1999-10 Impact factor: 8.171

3. Mutant WD-repeat protein in triple-A syndrome.

Authors: A Tullio-Pelet; R Salomon; S Hadj-Rabia; C Mugnier; M H de Laet; B Chaouachi; F Bakiri; P Brottier; L Cattolico; C Penet; M Bégeot; D Naville; M Nicolino; J L Chaussain; J Weissenbach; A Munnich; S Lyonnet
Journal: Nat Genet Date: 2000-11 Impact factor: 38.330

4. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.

Authors: V Annese; G Bassotti; G Coccia; M Dinelli; V D'Onofrio; G Gatto; G Leandro; A Repici; P A Testoni; A Andriulli
Journal: Gut Date: 2000-05 Impact factor: 23.059

5. Myenteric antiplexus antibodies and class II HLA in achalasia.

Authors: Antonio Ruiz-de-León; Juan Mendoza; Concepción Sevilla-Mantilla; Arquero Miguel Fernández; Julio Pérez-de-la-Serna; Vigo Ana Gónzalez; Enrique Rey; Angeles Figueredo; Manuel Díaz-Rubio; Emilio G De-la-Concha
Journal: Dig Dis Sci Date: 2002-01 Impact factor: 3.199

6. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.

Authors: Giovanni Zaninotto; Vito Annese; Mario Costantini; Alberto Del Genio; Michela Costantino; Magdalena Epifani; Giovanni Gatto; Vittorio D'onofrio; Luigi Benini; Sandro Contini; Daniela Molena; Giorgio Battaglia; Berardino Tardio; Angelo Andriulli; Ermanno Ancona
Journal: Ann Surg Date: 2004-03 Impact factor: 12.969

Review 7. Nitrates for achalasia.

Authors: Z H Wen; E Gardener; Y P Wang
Journal: Cochrane Database Syst Rev Date: 2004

8. Significant DQw1 association in achalasia.

Authors: R K Wong; C L Maydonovitch; S J Metz; J R Baker
Journal: Dig Dis Sci Date: 1989-03 Impact factor: 3.199

9. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia.

Authors: C S Robertson; B A Martin; M Atkinson
Journal: Gut Date: 1993-03 Impact factor: 23.059

10. Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial.

Authors: G Zaninotto; V Vergadoro; V Annese; M Costantini; M Costantino; D Molena; C Rizzetto; M Epifani; A Ruol; L Nicoletti; E Ancona
Journal: Surg Endosc Date: 2004-03-19 Impact factor: 4.584

10 in total

1. Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia.

Authors: Jason F Reynoso; Manish M Tiwari; Albert W Tsang; Dmitry Oleynikov
Journal: Surg Endosc Date: 2010-10-26 Impact factor: 4.584

Review 10. Idiopathic (primary) achalasia.

Authors: Farnoosh Farrokhi; Michael F Vaezi
Journal: Orphanet J Rare Dis Date: 2007-09-26 Impact factor: 4.123

10 in total

Non-surgical treatment of esophageal achalasia.

1. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study.

2. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.

3. Mutant WD-repeat protein in triple-A syndrome.

4. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.

5. Myenteric antiplexus antibodies and class II HLA in achalasia.

6. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.

Review 7. Nitrates for achalasia.

8. Significant DQw1 association in achalasia.

9. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia.

10. Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial.

1. Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia.

2. SAGES guidelines for the surgical treatment of esophageal achalasia.

3. Peroral endoscopic myotomy: a literature review and the first UK case series.

Review 4. Treatment and surveillance strategies in achalasia: an update.

5. Laparoscopic treatment for esophageal achalasia: experience at a single center.

6. Current clinical approach to achalasia.

7. Pneumatic balloon dilation therapy is as effective as esophagomyotomy for achalasia.

8. Management of achalasia.

Review 9. Idiopathic (primary) achalasia: a review.

Review 10. Idiopathic (primary) achalasia.